Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Press Releases.
Press releases published on August 27, 2025
Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico
GlobeNewswire
·
August 27, 2025
MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to …
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
MannKind to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Andrew Ross Joins Symbotic’s Board of Directors
GlobeNewswire
·
August 27, 2025
WILMINGTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the election of Andrew (“Andy”) Ross to its Board of Directors, effective August 26, 2025. …
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
GlobeNewswire
·
August 27, 2025
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
GlobeNewswire
·
August 27, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …
HP Inc. Reports Fiscal 2025 Third Quarter Results
GlobeNewswire
·
August 27, 2025
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.80, up 23.1% from the prior year period Third quarter non-GAAP diluted net EPS of $0.75, down 10.7% from the prior year …
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
GlobeNewswire
·
August 27, 2025
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its …
MDB Capital Holdings Provides Second Quarter 2025 Update
GlobeNewswire
·
August 27, 2025
Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025 …
Lantronix Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire
·
August 27, 2025
Fourth Quarter 2025 Net Revenue of $28.8 Million Fourth Quarter 2025 GAAP EPS of ($0.07) Fourth Quarter 2025 Non-GAAP EPS of $0.01 IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity …
Ingredion Incorporated Increases Quarterly Dividend to $0.82 per Share
GlobeNewswire
·
August 27, 2025
WESTCHESTER, Ill., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.82 per share on the Company’s common stock. The dividend is payable on Oct. 21, 2025, to stockholders of …
Key Tronic Corporation Announces Results for the Fourth Quarter and Year End of Fiscal Year 2025
GlobeNewswire
·
August 27, 2025
SPOKANE VALLEY, Wash., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its results for the quarter ended June 28, 2025. For the fourth quarter of fiscal year …
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 27, 2025
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025, in New York, …
Bicara Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that management will …
Metsera to Present at Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit …
Finanz Informatik Signs Long-Term Contract with Nutanix
GlobeNewswire
·
August 27, 2025
SAN JOSE, Calif. and FRANKFURT, Germany, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, and Finanz Informatik (FI), today announced that they have decided to enter into a strategic collaboration and have …
Nutanix Announces Increase to Share Repurchase Authorization
GlobeNewswire
·
August 27, 2025
SAN JOSE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its Board of Directors has authorized an increase of $350 million of common stock to the company’s existing share …
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …